parkinson's disease triple agonist glp-1 gip glucagon clinical trial Diabetes, obesity, and possible actions of The Role of Glucagon-like Peptide-1

Discover Weight Loss GLP-1 Tablets with Orforglipron in India

In recent years, there has been an increase in the morbidity, disability rate,and mortality due to obesity, making ...

Diabetic kidney disease, a common complication in patients with type 2 diabetes mellitus, is

Leah Joseph at Josephcarerx Clarifies the Key Differences Between GLP-1 and Ozempic to Help You Make Informed Health Decisions.

Using a global dataset and propensity matching, they found significantly lower mortality rates, major cardiovascular events (MACEs), and adverse kidney outcomes (MAKEs) among GLP-1 RA users compared to non-users

National Taiwan University researchers highlight the benefits of GLP-1 receptor agonists (GLP-1 RAs) in reducing mortality and severe cardiovascular and renal outcomes for diabetic patients with acute kidney disease (AKD)